Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS' EQUITY

v3.21.2
CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock Outstanding
Additional Paid-in Capital
Retained Earnings
Noncontrolling Interest
Noncontrolling Interest
Mezzanine
Equity, beginning balance at Dec. 31, 2019 $ 192,335 $ 36 $ 159,608 $ 31,905 $ 786 $ 168,725
Equity, beginning balance (in shares) at Dec. 31, 2019   35,908,057        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income 4,147     4,052 95 (1,160)
Purchase of noncontrolling interest 0         (126)
Shares issued for exercise of options and warrants (in shares)   151,601        
Shares issued for exercise of options and warrants 722   722      
Purchase of treasury shares (in shares)   (16,897)        
Purchase of treasury shares (301)   (301)      
Share-based compensation 1,058   1,058      
Dividends 0         (10,000)
Equity, ending balance at Mar. 31, 2020 197,961 $ 36 161,087 35,957 881 157,439
Equity, ending balance (in shares) at Mar. 31, 2020   36,042,761        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income 7,335     7,044 291 73,666
Purchase of noncontrolling interest 0       0 (125)
Cancellation of restricted stock awards (236)   (236)      
Shares issued for vesting of restricted stock awards (in shares)   24,453        
Shares issued for vesting of restricted stock awards 0          
Shares issued for exercise of options and warrants (in shares)   242,299        
Shares issued for exercise of options and warrants 2,283   2,283      
Share-based compensation 852   852      
Dividends (347)       (347) (20,000)
Equity, ending balance at Jun. 30, 2020 207,848 $ 36 163,986 43,001 825 210,980
Equity, ending balance (in shares) at Jun. 30, 2020   36,309,513        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income 16,902     16,713 189 8,522
Purchase of noncontrolling interest 0         (771)
Cancellation of restricted stock awards 0   0   0  
Shares issued for exercise of options and warrants (in shares)   399,787        
Shares issued for exercise of options and warrants 4,020 $ 1 4,019   0  
Shares issued for cashless exercise of warrants (shares)   66,517        
Shares issued for cashless exercise of warrants 0          
Share-based compensation 648   648   0  
Dividends 0 $ 0     0 (20,000)
Equity, ending balance at Sep. 30, 2020 229,418 $ 37 168,653 59,714 1,014 198,731
Equity, ending balance (in shares) at Sep. 30, 2020   36,775,817        
Equity, beginning balance at Dec. 31, 2020 330,911 $ 42 261,011 69,771 87 114,237
Equity, beginning balance (in shares) at Dec. 31, 2020   42,249,137        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income 13,698     13,151 547 760
Purchase of noncontrolling interest (75)       (75) (150)
Cancellation of restricted stock awards (in shares)   (5,281)        
Cancellation of restricted stock awards (144)   (144)      
Shares issued for vesting of restricted stock awards (in shares)   7,689        
Shares issued for vesting of restricted stock awards 0          
Shares issued for exercise of options and warrants (in shares)   421,002        
Shares issued for exercise of options and warrants 4,256 $ 1 4,255      
Purchase of treasury shares (in shares)   (34,158)        
Purchase of treasury shares (342)   (342)      
Share-based compensation 1,346   1,346      
Sales of noncontrolling interest 37       37  
Equity, ending balance at Mar. 31, 2021 349,687 $ 43 266,126 82,922 596 114,847
Equity, ending balance (in shares) at Mar. 31, 2021   42,638,389        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income 12,671     12,658 13 46,859
Purchase of noncontrolling interest           150
Cancellation of restricted stock awards (in shares)   (5,426)        
Cancellation of restricted stock awards (189)   (189)      
Shares issued for vesting of restricted stock awards (in shares)   22,284        
Shares issued for vesting of restricted stock awards 0          
Shares issued for exercise of options and warrants (in shares)   53,504        
Shares issued for exercise of options and warrants 561   561      
Purchase of treasury shares (in shares)   (100,000)        
Purchase of treasury shares (2,450)   (2,450)      
Share-based compensation 1,556   1,556      
Sale of shares by noncontrolling interest (in shares)   1,638,045        
Sale of shares by noncontrolling interest 40,133 $ 1 40,132      
Investment in noncontrolling interest 3,769       3,769  
Noncontrolling interest capital charge 10       10  
Dividends (1,156)       (1,156) (20,000)
Sales of noncontrolling interest 0       0  
Equity, ending balance at Jun. 30, 2021 404,582 $ 44 305,736 95,580 3,222 141,856
Equity, ending balance (in shares) at Jun. 30, 2021   44,246,796        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income 34,971     34,279 692 (40,356)
Shares issued for exercise of options and warrants (in shares)   190,254        
Shares issued for exercise of options and warrants 1,785   1,785      
Purchase of treasury shares (in shares)   (40,000)        
Purchase of treasury shares (2,947)   (2,947)      
Share-based compensation 1,420   1,420      
Investment in noncontrolling interest 500       500  
Dividends 0       0 (10,000)
Equity, ending balance at Sep. 30, 2021 $ 440,321 $ 44 $ 305,994 $ 129,859 $ 4,424 $ 91,500
Equity, ending balance (in shares) at Sep. 30, 2021   44,397,050